Anticomplementary activity of IVIG concentrates - Important assay parameters and impact of IgG polymers

Vox Sanguinis

Volumn 98, Issue 3 A, 2010, Pages

  Buchacher, A ^a   Schluga, P ^a   Mullner J ^a   Schreiner, M ^a   Kannicht, C ^b   Weinberger, J ^a  

^a Octapharma Pharmazeutika Produktions GmbH   (Austria)

^b Molecular Biochemistry   (Germany)

Author keywords

ACA; Aggregates; IgG; IVIG; Polymers

Indexed keywords

IMMUNOGLOBULIN G; POLYMER;

ACIDITY; ALKALINITY; ANIMAL CELL; ARTICLE; COMPLEMENT INHIBITION; CONTROLLED STUDY; DRUG FORMULATION; ERYTHROCYTE; GEL PERMEATION CHROMATOGRAPHY; HEAT TREATMENT; IMMUNOASSAY; IMMUNOGLOBULIN AGGREGATE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTIFACTS; CHROMATOGRAPHY, GEL; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; GUINEA PIGS; HEMOLYSIS; HOT TEMPERATURE; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INDICATORS AND REAGENTS; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS; SHEEP;

EID: 77449152013     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01271.x     Document Type: Article

References (21)

1. Barandun S, Kistler P, Jeunet F, Isliker H : Intravenous administration of human γ-globulin. Vox Sang 1962 7 : 157 174
2. Miekka SI, Gozze I : Anticomplementary activity of human Immunoglobulin G; I. Mechanism of the artifactual increase in anitcomplementary activity of IgG during assay. Vox Sang 1975 29 : 101 123
3. Kotitschke R, Harbauer G : Safety tests of the intravenous tolerance of immunoglobulins. Infusionstherapie 1992 19 : 23 28
4. Rousell RR, Budinger MD, Keppler DC, Victor R : Anticomplementary activity and the safety of intravenous immunoglobulin. Clin Therapeut 1989 11 : 143 150
5. European Pharmacopoeia : Human normal immunoglobulin for intravenous administration. European Pharmacopoeia 6.3, monograph 2.6.17, 4166 4168. Council of Europe, Strasbourg Cedex, France
6. Seiler FR, Kanzy EJ, Ax W, Hofstaetter T : Quality criteria for intravenous immunoglobulin preparations with emphasis on Fc-mediated functions and phagocytosis in Alving BM, Finlayson JS (eds Characterisation and Uses of Intravenous Preparations. Washington DC, DHEWPublication No. (FDA)-80-9005, US Government Printing Office, 1980 207 217
7. Soltis RD, Hasz D, Morris MJ, Wilson ID : The effect of heat inactivation of serum on aggregation of immunoglobulins. Immunology 1979 36 : 37 45 (Pubitemid 9229575)
8. Ramasamy I, Tran E, Farrugia A : Measurement of anticomplementary activity in therapeutic intravenous immunoglobulin preparations. Biologicals 1997 25 : 87 92
9. Zang XX, Sun Y, Shen F, Wang D, Zou L, Wang J, Kung E : Molecular structure alteration of IgG increases anticomplementary activity of intravenous immunoglobulin. Acta Pharm Sinica 1995 16 : 415 419
10. Gronski P, Kanzy EJ, Ronneberger HJ, Geursen R, Seiler FR : Quality criteria for i.v. immunoglobulins: importance of tests and product properties. Dev Biol Stand 1987 67 : 239 256
11. European Pharmacopoeia : Liquid Chromatography, European Pharmacopoeia 6.0, monograph 2.2.29, 46 47. Council of Europe, Strasbourg Cedex, France
12. European Pharmacopoeia : Size-Exclusion Chromatography, European Pharmacopoeia 6.0, Monograph 2.2.30, 47 48. Council of Europe, Strasbourg Cedex, France
13. European Pharmacopoeia : Test for Anticomplementary Activity of Immunoglobulin, European Pharmacopoeia 6.0, monograph 2.6.17, 191 193. Council of Europe, Strasbourg Cedex, France
14. Mayer MM : Complement and complement fixation in Thomas CC (ed Experimental Immunochemistry, Illinois, Springfield, 1961 133 240
15. Sandberg E, Daas A, Behr-Gross ME : Collaborative study to establish human BRP Batch 3 and human immunoglobulin (molecular size) BRP Batch 1. Pharmeuropa Bio 2006 1 : 37 47
16. Ahrer K, Buchacher A, Iberer G, Josic D, Jungbauer A : Analysis of aggregates of human immunoglobulin G using size-exclusion chromatography, static and dynamic light scattering. J Chromatogr A 2003 1009 : 89 96
17. Ahrer K, Buchacher A, Iberer G, Jungbauer A : Detection of aggregate formation during production of human immunoglobulin G by means of light scattering. J Chromatogr A 2004 1043 : 41 46
18. Ahrer K, Buchacher A, Iberer G, Jungbauer A : Effects of ultra-/diafiltration conditions on present aggregates in human immunoglobulin G preparations. J Memb Sci 2005 274 : 108 115
19. Friedli HR : Methodology and safety considerations in the production of an intravenous immunoglobulin preparation. Parmacotherapy 1987 7 (Suppl 2 36 40
20. Buchacher A, Iberer G, Jungbauer A, Schwinn H, Josic D : Continuous removal of protein aggregates by annular chromatography. Biotechnol Prog 2001 17 : 140 149 (Pubitemid 32145386)
21. Uemura Y, Uriyu K, Hirao Y, Takechi K, Ishikawa H, Nakajima T, Kagitani Y, Yokoyama K, Funakoshi S, Nishida M, Yabushita S, Furuta K, Hamamoto Y, Tochikura TS, Yamamoto N : Inactivation and elimination of viruses during the fractionation of an intravenous immunoglobulin preparation: liquid heat treatment and polyethylene glycol fractionation. Vox Sang 1989 56 : 155 161